$1.90
0.53% day before yesterday
NYSE, Dec 27, 10:16 pm CET
ISIN
US00857U1079
Symbol
AGL

Agilon Health Inc Stock price

$1.90
-0.21 9.95% 1M
-4.69 71.17% 6M
-10.65 84.86% YTD
-10.64 84.85% 1Y
-24.91 92.91% 3Y
-21.10 91.74% 5Y
-21.10 91.74% 10Y
NYSE, Closing price Fri, Dec 27 2024
+0.01 0.53%
ISIN
US00857U1079
Symbol
AGL
Sector

Key metrics

Market capitalization $782.83m
Enterprise Value $428.17m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.08
P/S ratio (TTM) P/S ratio 0.14
P/B ratio (TTM) P/B ratio 1.36
Revenue growth (TTM) Revenue growth 33.49%
Revenue (TTM) Revenue $5.59b
EBIT (operating result TTM) EBIT $-343.59m
Free Cash Flow (TTM) Free Cash Flow $-149.28m
Cash position $398.56m
EPS (TTM) EPS $-0.82
P/E forward negative
P/S forward 0.13
EV/Sales forward 0.07
Short interest 30.66%
Show more

Is Agilon Health Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Agilon Health Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Agilon Health Inc forecast:

3x Buy
14%
15x Hold
71%
3x Sell
14%

Analyst Opinions

21 Analysts have issued a Agilon Health Inc forecast:

Buy
14%
Hold
71%
Sell
14%

Financial data from Agilon Health Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
5,594 5,594
33% 33%
100%
- Direct Costs 5,669 5,669
40% 40%
101%
-74 -74
148% 148%
-1%
- Selling and Administrative Expenses 246 246
12% 12%
4%
- Research and Development Expense - -
-
-
-321 -321
162% 162%
-6%
- Depreciation and Amortization 23 23
20% 20%
0%
EBIT (Operating Income) EBIT -344 -344
143% 143%
-6%
Net Profit -336 -336
279% 279%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about Agilon Health Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Agilon Health Inc Stock News

Neutral
Seeking Alpha
about 2 months ago
agilon health, inc. (NYSE:AGL ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Leland Thomas - Senior Manager-Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Adam Ron - Bank of America George Hill - Deutsche Bank Sameer Patel - Ev...
Negative
Seeking Alpha
about 2 months ago
I initially rated agilon health, inc. as a “hold” due to its volatile financial results and uncertain future, but recent developments necessitate a downgrade to 'sell'. The company's stock plummeted 60.1% since my last article, driven by disappointing Q3 results and reduced guidance, despite revenue growth. Rising medical costs and expansion expenses have severely impacted profitability, with a...
Neutral
Business Wire
about 2 months ago
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wolfe Research Healthcare Conference including a fireside chat presentation on Tuesday, November 19, at 2:20 PM Eastern Time. A simultaneous webcast for the event can be accessed by visiting the “Ev...
More Agilon Health Inc News

Company Profile

Agilon Health, Inc. engages in providing necessary capabilities, capital, and business model for existing physician groups to create a Medicare-centric, globally capitated line of business. It offers Total Care Model that focuses exclusively on Medicare and manages the comprehensive healthcare needs of its members through subscription-like member per month arrangements with health plans or directly with Centers for Medical and Medicard services. The company was founded in 2016 and is headquartered in Long Beach, CA.

Head office United States
CEO Steven Sell
Employees 1,117
Founded 2016
Website www.agilonhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today